Operating Lease, Liability, Current of Anika Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary: Anika Therapeutics, Inc. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
Anika Therapeutics, Inc. Operating Lease, Liability, Current for the quarter ending 30 Sep 2025 was $1,725,000, a 25% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Current, Quarterly (USD)

Operating Lease, Liability, Current, YoY Quarterly Change (%)

Anika Therapeutics, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,725,000	-$567,000	-25%	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$1,815,000	-$472,000	-21%	30 Jun 2025	10-Q	30 Jul 2025	2025	Q2
Q1 2025	$1,874,000	-$255,000	-12%	31 Mar 2025	10-Q	09 May 2025	2025	Q1
Q4 2024	$1,918,000	+$91,000	+5%	31 Dec 2024	10-Q	05 Nov 2025	2025	Q3
Q3 2024	$2,292,000			30 Sep 2024	10-Q	04 Nov 2024	2024	Q3
Q2 2024	$2,287,000			30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$2,129,000			31 Mar 2024	10-Q	08 May 2024	2024	Q1
Q4 2023	$1,827,000			31 Dec 2023	10-K	17 Mar 2025	2024	FY
Q3 2020	$1,463,000	+$354,000	+32%	30 Sep 2020	10-Q	05 Nov 2020	2020	Q3
Q2 2020	$1,476,000	+$375,000	+34%	30 Jun 2020	10-Q	07 Aug 2020	2020	Q2
Q1 2020	$1,481,000	+$406,000	+38%	31 Mar 2020	10-Q	22 May 2020	2020	Q1
Q4 2019	$1,141,000			31 Dec 2019	10-Q	05 Nov 2020	2020	Q3
Q3 2019	$1,109,000			30 Sep 2019	10-Q	28 Oct 2019	2019	Q3
Q2 2019	$1,101,000			30 Jun 2019	10-Q	26 Jul 2019	2019	Q2
Q1 2019	$1,075,000			31 Mar 2019	10-Q	06 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.